| A randomized trial of factor VIII and neutralizing antibodies in hemophilia A F Peyvandi, PM Mannucci, I Garagiola, A El-Beshlawy, M Elalfy, ... New England Journal of Medicine 374 (21), 2054-2064, 2016 | 530 | 2016 |
| Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study D Mohanty, RB Colah, AC Gorakshakar, RZ Patel, DC Master, J Mahanta, ... Journal of community genetics 4, 33-42, 2013 | 291 | 2013 |
| Guidelines for screening, diagnosis and management of hemoglobinopathies K Ghosh, R Colah, M Manglani, VP Choudhry, I Verma, N Madan, ... Indian journal of human genetics 20 (2), 101, 2014 | 66 | 2014 |
| ABO blood groups and malaria related clinical outcome. D Deepa, VA Alwar, KR Karuna Rameshkumar, C Ross | 53 | 2011 |
| Timing and severity of inhibitor development in recombinant versus plasma‐derived factor VIII concentrates: a SIPPET analysis F Peyvandi, A Cannavò, I Garagiola, R Palla, PM Mannucci, ... Journal of Thrombosis and Haemostasis 16 (1), 39-43, 2018 | 50 | 2018 |
| RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target P Thomas, A Pranatharthi, C Ross, S Srivastava Journal of Experimental & Clinical Cancer Research 38, 1-11, 2019 | 49 | 2019 |
| Influence of CYP2C9 and VKORC1 gene polymorphisms on warfarin dosage, over anticoagulation and other adverse outcomes in Indian population T Gaikwad, K Ghosh, B Kulkarni, V Kulkarni, C Ross, S Shetty European journal of pharmacology 710 (1-3), 80-84, 2013 | 46 | 2013 |
| Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial G Young, A Srivastava, K Kavakli, C Ross, J Sathar, CW You, H Tran, ... The Lancet 401 (10386), 1427-1437, 2023 | 42 | 2023 |
| An ingenious non-spherical mesoporous silica nanoparticle cargo with curcumin induces mitochondria-mediated apoptosis in breast cancer (MCF-7) cells L Harini, S Srivastava, GP Gnanakumar, B Karthikeyan, C Ross, ... Oncotarget 10 (11), 1193, 2019 | 42 | 2019 |
| RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer A Pranatharthi, P Thomas, AH Udayashankar, C Bhavani, SB Suresh, ... Journal of Experimental & Clinical Cancer Research 38, 1-24, 2019 | 41 | 2019 |
| Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency C Ross, S Rangarajan, M Karimi, G Toogeh, S Apte, T Lissitchkov, ... Journal of Thrombosis and Haemostasis 16 (2), 253-261, 2018 | 41 | 2018 |
| Source of factor VIII replacement (plasmatic or recombinant) and incidence of inhibitory alloantibodies in previously untreated patients with severe hemophilia A: the … F Peyvandi, PM Mannucci, I Garagiola, M Elalfy, A El-Beshlawy, ... Blood 126 (23), 5, 2015 | 36 | 2015 |
| Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement S Spena, I Garagiola, A Cannavò, M Mortarino, PM Mannucci, ... Journal of Thrombosis and Haemostasis 16 (4), 778-790, 2018 | 34 | 2018 |
| Heterogeneity of peripheral blood monocyte populations in human immunodeficiency virus-1 seropositive patients PM Abel, C McSharry, E Galloway, C Ross, A Severn, G Toner, L Gruer, ... FEMS microbiology immunology 5 (5-6), 317-323, 1992 | 33 | 1992 |
| Factor XIII deficiency: a rare cause of repeated abortions LD Padmanabhan, R Mhaskar, A Mhaskar, CR Ross Singapore medical journal 45 (4), 186-187, 2004 | 32 | 2004 |
| Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients T Lissitchkov, B Madan, CD Khayat, N Zozulya, C Ross, M Karimi, ... Journal of Thrombosis and Haemostasis 18 (4), 815-824, 2020 | 28 | 2020 |
| Cancer stem cells and radioresistance: Rho/ROCK pathway plea attention A Pranatharthi, C Ross, S Srivastava Stem Cells International 2016 (1), 5785786, 2016 | 28 | 2016 |
| Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia A Casini, S von Mackensen, C Santoro, C Djambas Khayat, M Belhani, ... Blood, The Journal of the American Society of Hematology 137 (22), 3127-3136, 2021 | 24 | 2021 |
| Efficacy and safety of a new human fibrinogen concentrate in patients with congenital fibrinogen deficiency: an interim analysis of a Phase III trial T Lissitchkov, B Madan, C Djambas Khayat, N Zozulya, C Ross, M Karimi, ... Transfusion 58 (2), 413-422, 2018 | 23 | 2018 |
| MiRNA182 regulates percentage of myeloid and erythroid cells in chronic myeloid leukemia D Arya, SP Sachithanandan, C Ross, D Palakodeti, S Li, S Krishna Cell death & disease 8 (1), e2547-e2547, 2018 | 23 | 2018 |
